NCT05649826 Automated Ultrasound Cardiac Guidance Tool
| NCT ID | NCT05649826 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UltraSight |
| Condition | Ultrasound Imaging |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2027-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-02-01 with a primary completion date of 2027-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research examines echocardiography images taken from cardiac patients in relation to the guidance tool developed
Eligibility Criteria
Inclusion Criteria: 1. Males and females, aged 18 years and older 2. Subject willing and able to give written informed consent Exclusion Criteria: 1. Emergency (non-elective) admission within 24 h prior to participating in the study 2. Female subjects who are pregnant (women of childbearing potential will provide a statement that they are not pregnant incorporated in the ICF 3. Unable to lie as required in all the classic positions for standard TTE exam: supine on back / left decubitus 4. Subjects who currently participate in a clinical trial, involving interventional cardiac devices. 5. Subjects who have prior Echo exam with description of Low/Poor quality exam in the echo report. 6. Subjects with BMI above 40. 7. Subjects experiencing a known or suspected acute cardiac event. 8. Subjects with severe chest wall deformity as per previous medical records and physical examination. 9. Subjects who have undergone pneumonectomy. 10. Subjects whose anatomy does not lend itself to yield diagnosable standard echocardiography clips (i.e., situs inversus with dextrocardia, single ventricle anatomy due to congenital heart disease, etc.).
Contact & Investigator
Robert Ehrman, MD
PRINCIPAL INVESTIGATOR
Wayne University Emergency medicine
Frequently Asked Questions
Who can join the NCT05649826 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Ultrasound Imaging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05649826 currently recruiting?
Yes, NCT05649826 is actively recruiting participants. Contact the research team at rehrman@med.wayne.edu for enrollment information.
Where is the NCT05649826 trial being conducted?
This trial is being conducted at Detroit, United States.
Who is sponsoring the NCT05649826 clinical trial?
NCT05649826 is sponsored by UltraSight. The principal investigator is Robert Ehrman, MD at Wayne University Emergency medicine. The trial plans to enroll 200 participants.